Related Experiment Video
Updated: Aug 8, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
[Advances in diagnosis and treatment of familial hypercholesterolemia]
1Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Insights
Familial hypercholesterolemia (FH) is an inherited disorder increasing coronary artery disease risk. Gene detection and LDL receptor (LDLR) function analysis are key for FH diagnosis and treatment.
Area of Science:
- Cardiovascular Genetics
- Metabolic Disorders
- Molecular Biology
Background:
- Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder impacting lipoprotein metabolism.
- Elevated low-density lipoprotein (LDL) levels in FH patients significantly heighten the risk of developing coronary artery disease (CAD).
Conclusions:
- Comprehensive screening and accurate diagnosis are vital for managing FH.
- Functional analysis of LDLR mutations provides insights for personalized therapeutic strategies.
- Effective management of FH can reduce the long-term burden of cardiovascular disease.
Abstract:
Familial hypercholesterolemia (FH) is an autosomal dominant inherited disease caused by abnormal lipoprotein metabolism. Patients with FH have a significantly increased risk of coronary artery disease (CAD) due to long-term exposure to high levels of low-density lipoprotein (LDL). The diagnosis of FH relies heavily on gene detection, and examination of LDL receptor (LDLR) function is of great significance in its treatment. This review summarizes the current advances in the screening, diagnosis, and treatment of FH and functional analysis of LDLR gene mutations.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction

